MEDI4736
D4191C00001
Phase 3 small_molecule completed
Quick answer
MEDI4736 for Non-Small Cell Lung Cancer is a Phase 3 program (small_molecule) at AstraZeneca with 1 ClinicalTrials.gov record(s).
Program details
- Company
- AstraZeneca
- Indication
- Non-Small Cell Lung Cancer
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- completed